Cite as: Cold Spring Harb. Protoc.; 2008; doi:10.1101/pdb.prot5003
| Protocol |
This protocol was adapted from "DNA Linear Amplification," Chapter 7, in Whole Genome Amplification: Methods Express (eds. Hughes and Laskin), from the Methods Express series. Scion Publishing Ltd., Oxfordshire, UK, 2005.
INTRODUCTION
T7-based linear amplification of DNA (TLAD) uses a linear amplification approach based on in vitro transcription (IVT) of template DNA by RNA polymerase from the T7 phage. TLAD was designed primarily for use with the ChIP-chip method (whereby DNA recovered from chromatin immunoprecipitation [ChIP] of cell lysate is used for subsequent analysis on DNA microarrays) and requires nanogram quantities of dsDNA to generate microgram amounts of amplified RNA. Briefly, the strategy is to add a 3' conserved end to the template dsDNA, using terminal deoxynucleotidyl transferase (TdT) tailing, which permits the addition of a T7 promoter sequence in the subsequent second-strand synthesis step, described here. At this stage, the strand-displacement activity of the Klenow fragment polymerase separates the two strands of the template DNA, after which the enzyme performs fill-in 5'
3' polymerization. Its 3'
5' exonuclease activity may also remove the 3' overhanging poly(dT) tails, although the efficiency of this activity will vary based on the length of the poly(dT) tail. IVT can then use this newly appended T7 promoter. Because the T7-based IVT proceeds as an isothermal reaction, it linearly amplifies the template DNA, producing antisense RNA (aRNA) (i.e., each strand of RNA produced is antisense to the original template strand). Since both strands are amplified, this distinction is usually not important and is affected only by the location of the T7 promoter and poly(A) tract on the aRNA.
RELATED INFORMATION
Information about ChIP-chip and an overview of the TLAD method (including suggested controls and interpretation of results) is provided in Whole Genome Amplification by T7-Based Linear Amplification of DNA (TLAD): Overview (Liu et al. 2008a). The articles Whole Genome Amplification by T7-Based Linear Amplification of DNA (TLAD): I. CIP Treatment of Samples and Tailing Reaction with Terminal Transferase (Liu et al. 2008b) and Whole Genome Amplification by T7-Based Linear Amplification of DNA (TLAD): III. Sample Purification (Liu et al. 2008c) detail Parts I and III (respectively) of the TLAD method. TLAD was originally described by Liu et al. (2003); a schematic of the method is shown in Figure 1 .
![]() View larger version (17K): [in a new window] |
Figure 1. General strategy for the TLAD method. Starting with dsDNA template, TdT is used to add a poly(dT) tail to the 3'-ends of the template. This tail subsequently provides a conserved binding site for the annealing of T7 promoter (pT7)-poly(dA) primer adapters. Following subsequent second-strand synthesis using the large fragment of DNA polymerase I (Klenow fragment), one pair of dsDNA templates, with each pair member representing one of the two complementary strands of the dsDNA, is generated, with a T7 promoter at the 5'-end of the amplicon. In the subsequent IVT step, RNA is transcribed from this template in an isothermal reaction, producing an RNA amplification product consisting of both strands of the original dsDNA template in high microgram quantities. Note that each RNA strand will contain a short sequence from the T7 promoter and a poly(A) tract, 5' relative to the amplicon. (Reprinted with permission from Liu et al. [2003].)
|
Reagents
DNA polymerase I Klenow fragment (5000 units/mL) (New England Biolabs)
DNA template from Whole Genome Amplification by T7-Based Linear Amplification of DNA (TLAD): I. CIP Treatment of Samples and Tailing Reaction with Terminal Transferase (Liu et al. 2008a) [poly(dT)-tailed]
dNTP mix (5.0 mM) (Invitrogen)
This is a deoxynucleotide mixture containing 5 mM each of dATP, dCTP, dTTP, and dUTP. Avoid subjecting the dNTP mix to more than three freeze-thaw cycles. Additional freeze-thaw cycles will further degrade the dNTPs and reduce the reaction yield.
H2O (nuclease-free)
MinElute Reaction Cleanup kit (containing MinElute columns; Buffer ERC; Buffer PE; Buffer EB) (QIAGEN)
Add 95% or 100% RNase-free ethanol to Buffer PE before use; see manufacturers protocol.
NEB Buffer 2 (New England Biolabs)
In early 2004, New England Biolabs switched the supplied buffer for the Klenow enzyme from EcoPol Buffer (10 mM Tris-HCl at pH 7.5; 5 mM MgCl2; 7.5 mM DTT) to NEB Buffer 2. NEB Buffer 2 is typically supplied with the Klenow fragment enzyme and contains the following: 50 mM NaCl; 10 mM Tris-HCl (pH 7.9); 10 mM MgCl2; 1 mM DTT. NEB Buffer 2 performs at least equivalently, if not better, than the EcoPol Buffer, which had to be pre-warmed to 37°C to dissolve any precipitated DTT.
Primer adapter: T7-A18B (5'-GCATTAGCGGCCGCGAAATTAATACGACTCACTATAGGGAG(A)18[B]-3') (25 µM)
[B] stands for any base other than A; the primer thus consists of a mix of primers that end in C, G, or T. This primer adapter should be obtained by high-pressure liquid chromatography, polyacrylamide gel electrophoresis, or an equivalent purification method.
Sodium acetate (3 M, pH 5.0) (optional; see Step 6)
T7 Megascript Kit (containing 75 mM each of ATP, CTP, GTP, and UTP nucleotide solutions; pTRI-Xef [0.5 mg/mL] control template [optional]; nuclease-free H2O; 10X reaction buffer; 10X enzyme mix [T7 RNA polymerase and a proprietary RNase inhibitor]) (Ambion)
If using a new kit, combine the NTP solutions into one tube, then aliquot back out into the four tubes. In the first three freeze-thaw cycles, yields drop ~10%-15% after each cycle. If the NTPs go through more than three freeze-thaw cycles, each subsequent freeze-thaw cycle may additionally drop the yield by as much as 50%.
Warm 10X reaction buffer to room temperature before use.
Equipment
Air incubator preset to 37°C
Microcentrifuge
Thermal cycler
Tubes (0.2-mL thermal cycler-compatible, RNase-free)
0.2 mL-tubes are used to minimize vapor volume (Step 13).
Vacuum centrifuge
METHOD
RNA is produced at the end of this protocol; practice correct techniques to maintain an RNase-free environment.
Second-Strand Synthesis with Klenow Fragment Polymerase
|
These volumes correspond to a typical reaction volume of 25 µL, taking into account the 1 µL of Klenow polymerase to be added in Step 3. The volume should be scaled up to 50 µL if the tailing reaction in Step 9 of Whole Genome Amplification by T7-Based Linear Amplification of DNA (TLAD): I. CIP Treatment of Samples and Tailing Reaction with Terminal Transferase (Liu et al. 2008a) was scaled up to 20 µL. Refer to Table 1, which contains optimized primer amounts and recommended final reaction volumes for a given starting amount of DNA, for any necessary adjustments.
Avoid use of mineral oil, because trace amounts of mineral oil may interfere with the IVT reaction (Steps 11-13).
| ||||||||||||||
A pause of up to 5 min at 25°C is permitted if time is needed for adding Klenow to a large number of samples.
Sample Purification using MinElute Columns
This method is based on the MinElute Reaction Cleanup kit protocol provided in the MinElute Handbook (supplied with the kit), except that the elution volume has been doubled from 10 µL to 20 µL because of the small amounts of DNA being purified at each step. Without this increase in elution volume, yields may drop by as much as 50% (possibly because the MinElute columns have a decreased recovery yield for nanogram quantities of DNA).
In Vitro Transcription (IVT)
|
If the template DNA is small (<300 bp), it may be helpful to boost the reaction by increasing the enzyme mix to 2.4 µL and decreasing the NTP mix to 7.6 µL. The reaction yield may increase by 10%-30% because of the more favorable stoichiometric ratio of enzyme to template DNA in the boosted reaction. However, since this may lower the maximum theoretical yield, this step is not recommended for larger DNA templates.
Warm reaction buffer to room temperature before addition. Addition of cold buffer to the template DNA risks precipitation of the DNA.
TROUBLESHOOTING
Troubleshooting information (including information about generation of template-independent product during second-strand synthesis) for this protocol and the related TLAD articles in this set (Parts I and III; see Related Information) is available in the Troubleshooting section of Whole Genome Amplification by T7-Based Linear Amplification of DNA (TLAD): III. Sample Purification (Liu et al. 2008c).
ACKNOWLEDGMENTS
C.L.L. is supported by a Graduate Research Fellowship from the National Science Foundation. S.L.S. is an investigator at the Howard Hughes Medical Institute. B.E.B. is supported by a K08 Development Award from the National Cancer Institute. This work was supported by a grant from the National Institute for General Medical Sciences.
REFERENCES
Liu, C.L., Schreiber, S.L., and Bernstein, B.E. 2003. Development and validation of a T7 based linear amplification for genomic DNA. BMC Genomics 4: 19. doi: 10.1186/1471-2164-4-19.[Medline]
Liu, C.L., Bernstein, B.E., and Schreiber, S.L. 2008a. Whole genome amplification by T7-based linear amplification of DNA (TLAD): Overview. CSH Protocols (this issue) doi: 10.1101/pdb.top42.
Liu, C.L., Bernstein, B.E., and Schreiber, S.L. 2008b. Whole genome amplification by T7-based linear amplification of DNA (TLAD): I. CIP treatment of samples and tailing reaction with terminal transferase. CSH Protocols (this issue) doi: 10.1101/pdb.prot5002.
Liu, C.L., Bernstein, B.E., and Schreiber, S.L. 2008c. Whole genome amplification by T7-based linear amplification of DNA (TLAD): III. Sample purification. CSH Protocols (this issue) doi: 10.1101/pdb.prot5004.
Related Article
Related Protocols
This article has been cited by other articles:
![]() |
C. L. Liu, B. E. Bernstein, and S. L. Schreiber Whole Genome Amplification by T7-Based Linear Amplification of DNA (TLAD): Overview CSH Protocols, May 1, 2008; 2008(6): pdb.top42 - pdb.top42. [Abstract] [Full Text] |
||||
![]() |
C. L. Liu, B. E. Bernstein, and S. L. Schreiber Whole Genome Amplification by T7-Based Linear Amplification of DNA (TLAD): I. CIP Treatment of Samples and Tailing Reaction with Terminal Transferase CSH Protocols, May 1, 2008; 2008(6): pdb.prot5002 - pdb.prot5002. [Abstract] [Full Text] |
||||
![]() |
C. L. Liu, B. E. Bernstein, and S. L. Schreiber Whole Genome Amplification by T7-Based Linear Amplification of DNA (TLAD): III. Sample Purification CSH Protocols, May 1, 2008; 2008(6): pdb.prot5004 - pdb.prot5004. [Abstract] [Full Text] |
||||
Copyright © 2008 by Cold Spring Harbor Laboratory Press. Online ISSN: 1559-6095 Terms of Service |